Gordon syndrome

Reading Document

Medical Text Search

Gordon syndrome pseudohypoaldosteronism type 2 clinical features genetics

Medical Text Search

Gordon syndrome hyperkalemia hypertension WNK kinase diagnosis treatment

GradeResponse

Medical Text Search

pseudohypoaldosteronism type 2 hyperkalemia hypertension thiazide diuretics pathophysiology

Based on what was retrieved and my medical knowledge, here is a comprehensive overview of Gordon syndrome.

Gordon Syndrome (Pseudohypoaldosteronism Type II / PHA II)

Gordon syndrome, also called Pseudohypoaldosteronism Type II (PHA II) or familial hyperkalemic hypertension (FHH), is a rare inherited disorder of renal tubular electrolyte handling characterized by the triad of hyperkalemia, hypertension, and normal or reduced GFR, despite otherwise normal or elevated aldosterone levels. (Harrison's Principles of Internal Medicine, 21st Ed., p. 353, 2080)

Etiology & Genetics

Gordon syndrome is caused by gain-of-function mutations that enhance sodium chloride reabsorption in the distal nephron, particularly the distal convoluted tubule (DCT). The key molecular players are the WNK (With No lysine K) serine-threonine kinases:

Gene	Locus	Inheritance	Notes
WNK1	12p13	Autosomal dominant	Intronic deletion → overexpression
WNK4	17q21	Autosomal dominant	Missense mutations → loss of inhibition of NCC
KLHL3	5q31	AD or AR	Adaptor protein targeting WNKs for degradation
CUL3	2q36	Autosomal dominant	E3 ubiquitin ligase; often de novo, more severe

CUL3 mutations tend to be de novo and cause the most severe phenotype, with earlier onset and more pronounced hyperkalemia and hypertension.
The final common pathway is increased activity of the NCC (Na-Cl cotransporter, SLC12A3) in the DCT, leading to excess sodium reabsorption and impaired potassium/H⁺ secretion.

Pathophysiology

↑ NCC activity → increased Na⁺/Cl⁻ reabsorption in DCT
↓ Na⁺ delivery to the collecting duct → reduced driving force for potassium secretion via ROMK channels → hyperkalemia
Volume expansion from Na⁺ retention → hypertension (aldosterone-independent)
Reduced H⁺ secretion in collecting duct → metabolic acidosis (hyperchloremic)
Aldosterone levels are normal or elevated but functionally "opposed" by downstream NCC activity — hence the "pseudohypoaldosteronism" misnomer

Clinical Features (Harrison's, p. 353, 2080)

Hypertension — often severe, can present in childhood or early adulthood
Hyperkalemia — chronic, often asymptomatic unless severe (muscle weakness, arrhythmia risk)
Hyperchloremic metabolic acidosis (normal anion gap)
Normal or reduced GFR (no intrinsic renal disease)
Short stature — in some cases
Muscle weakness — secondary to hyperkalemia
Aldosterone levels normal or elevated but urinary K⁺ excretion paradoxically low

Diagnosis

Suspected when:

Hypertension + hyperkalemia in the absence of renal insufficiency
No medications (e.g., ACE inhibitors, potassium-sparing diuretics) causing hyperkalemia
Family history of hypertension and/or hyperkalemia

Key laboratory findings:

Finding	Value
Serum K⁺	↑ (often 5.5–7 mEq/L)
Serum Cl⁻	↑ (hyperchloremia)
Bicarbonate	↓ (metabolic acidosis)
Plasma renin	Low–normal (suppressed by volume expansion)
Aldosterone	Normal or elevated
Urinary K⁺ excretion	Low relative to serum K⁺
GFR	Normal or mildly reduced

Differentiation from other causes of hyperkalemia + hypertension:

Primary hyperaldosteronism: hyperkalemia is absent (hypokalemia instead)
Chronic kidney disease: GFR is reduced and explains hyperkalemia
PHA type I: presents in neonates, salt-wasting, hypotension — not hypertension
Liddle syndrome: hypokalemia + low aldosterone (gain-of-function ENaC)

Genetic testing for WNK1, WNK4, KLHL3, CUL3 mutations confirms the diagnosis.

Treatment (Harrison's, p. 353)

The treatment of Gordon syndrome is remarkably effective and pharmacologically elegant — the molecular defect (excess NCC activity) is directly targeted:

First-Line: Thiazide Diuretics

Hydrochlorothiazide or chlorthalidone — block NCC directly
Often produce dramatic normalization of both blood pressure and serum potassium
This therapeutic response is itself near-diagnostic
Low doses are typically sufficient

Dietary

Low-sodium diet — reduces substrate for excess NCC-mediated reabsorption
Complements pharmacologic therapy

Additional Measures

Correction of metabolic acidosis if severe (sodium bicarbonate supplementation)
Avoid medications that worsen hyperkalemia (NSAIDs, ACE inhibitors/ARBs — use with caution, though paradoxically RAS blockade can help BP)

Prognosis

Excellent with treatment — patients on thiazides have normalized electrolytes and blood pressure
Untreated, chronic hypertension leads to cardiovascular and end-organ complications
CUL3 mutations may require higher doses or combination therapy due to phenotypic severity

Summary

Gordon syndrome (PHA II) is a rare but clinically important monogenic cause of hypertension that should be suspected in any patient with hypertension + hyperkalemia + normal renal function. Its molecular basis in WNK-SPAK-NCC signaling makes it a model for understanding distal tubular physiology, and its exquisite response to thiazide diuretics makes it one of the most satisfying diagnoses in nephrology.

Perilunate dislocation x ray with explanation about how to diagnose it

Reading Document

Medical Image Search

perilunate dislocation wrist X-ray radiograph

Medical Text Search

perilunate dislocation X-ray radiographic diagnosis findings Gilula arcs

GradeResponse

Here is a comprehensive breakdown of how to diagnose perilunate dislocation on X-ray.

Perilunate Dislocation — X-Ray Diagnosis

The X-Ray

Perilunate dislocation AP and lateral X-rays showing disrupted Gilula's lines and dorsal capitate displacement

AP (left) and lateral (right) wrist radiographs demonstrating a dorsal perilunate dislocation. Note the disrupted carpal arcs on AP view, and the dorsally displaced capitate relative to a lunate that remains seated against the radius on the lateral view. An avulsion fracture of the dorsal horn of the lunate (white arrowhead) and ulnar styloid tip fracture are also visible.

What Is Perilunate Dislocation?

In a perilunate dislocation, the lunate stays in its normal fossa against the distal radius, but the entire rest of the carpus (led by the capitate) dislocates — most commonly dorsally — around it. This follows high-energy hyperextension injury (e.g., fall on outstretched hand, motor vehicle accident).

It sits in a progressive injury spectrum (Mayfield stages I–IV):

Stage	Injury
I	Scapholunate dissociation
II	Capitolunate dislocation (perilunate)
III	Lunotriquetral disruption
IV	Lunate dislocation (lunate flips volar)

How to Read the X-Ray: Step-by-Step

View 1: PA/AP Radiograph

Step 1 — Check Gilula's Lines (Three Carpal Arcs)

Gilula's lines are three smooth, parallel arcs drawn across the proximal carpal row in a normal wrist:

Arc	Traces along
Arc I	Proximal articular surfaces of scaphoid, lunate, triquetrum
Arc II	Distal articular surfaces of scaphoid, lunate, triquetrum
Arc III	Proximal articular surfaces of capitate and hamate

In perilunate dislocation: all three arcs are disrupted. The carpal bones overlap abnormally. The proximal and distal rows are no longer parallel.

Step 2 — Look at the Lunate Shape

Normally the lunate appears quadrilateral on AP view
In perilunate dislocation, it may appear triangular ("pie-shaped") due to rotational tilt — this is even more pronounced in a full lunate dislocation

Step 3 — Look for Carpal Crowding / Overlap

The capitate appears superimposed over or proximally displaced relative to its normal position
There is loss of joint space between the carpal rows
The scapholunate interval may be widened >3 mm (Terry Thomas sign) if there is associated scapholunate ligament injury

Step 4 — Look for Associated Fractures

Trans-scaphoid perilunate dislocation is the most common variant — the scaphoid fractures through its waist instead of the ligament tearing
Also check for: radial styloid fracture, ulnar styloid avulsion fracture, lunate dorsal horn avulsion

View 2: Lateral Radiograph — The Key View

The lateral view is diagnostic and is where perilunate dislocation is most clearly identified.

The Normal Lateral Alignment Rule

On a true lateral wrist X-ray, three bones should form a straight line:

Radius → Lunate (cup) → Capitate (sits in lunate cup) → 3rd metacarpal

The capitate sits inside the concave distal surface of the lunate, and the lunate sits in the lunate fossa of the radius.

What You See in Perilunate Dislocation

Structure	Position
Radius	Normal
Lunate	✅ Remains seated in radial fossa — in normal position
Capitate	❌ Displaced dorsally (posteriorly) — no longer sitting in the lunate cup
Rest of carpus	Rides dorsally with the capitate

Memory aid: "The lunate stays, everything else runs away — dorsally."

In contrast, in lunate dislocation (Stage IV):

The capitate returns to alignment with the radius
But the lunate is spilled volar (anteriorly), often compressing the median nerve → carpal tunnel syndrome

Summary: AP vs Lateral Findings

Feature	AP View	Lateral View
Gilula's arcs	Disrupted	N/A
Lunate shape	May appear triangular	Seated normally on radius
Capitate position	Overlapping/proximally displaced	Dorsally displaced off lunate
Scapholunate gap	May be >3 mm	—
Associated fractures	Scaphoid waist, radial/ulnar styloid	Lunate dorsal horn avulsion

Common Pitfall

Perilunate dislocation is missed in up to 25% of cases on initial presentation because:

The AP view can look deceptively subtle
Swelling distracts from careful X-ray analysis
The lateral view is not obtained or is a poor true lateral

Always get a true lateral view and trace the radius–lunate–capitate alignment in any wrist trauma with significant swelling or mechanism.

Next Steps After X-Ray Diagnosis

CT scan — better delineates associated fractures (especially scaphoid)
MRI — assesses ligamentous injury if CT is inconclusive
Urgent orthopedic/hand surgery referral — closed reduction under anesthesia, followed by surgical fixation in most cases
Monitor for median nerve injury (acute carpal tunnel syndrome) — present in ~25% of cases (Bailey & Love's Surgery, 28th Ed., p. 455)

This is a shared conversation. Sign in to Orris to start your own chat.